Study: Cannabis a Potential Treatment Option for Insulin Resistance and Obesity-Related Diabetes

Activation of the cannabinoid 2 receptor – done naturally through the consumption of cannabis and cannabinoids – may be a potential treatment option for insulin resistance and obesity-related diabetes.

 Insulin ResistanceThis is according to new research out of the Institute of Biomedical Engineering at the Chinese Academy of Medical Science; the study was study published in the journal Cellular Physiology and Biochemistry, and epublished by the U.S. National Institute of Health.

“The endocannabinoid signalling (ECS) system has been known to regulate glucose homeostasis”. states the study’s abstract. “Previous studies have suggested that the cannabinoid 2 (CB2) receptor may play a regulatory role on insulin secretion, immune modulation and insulin resistance.”

Given that diabetes and insulin resistance are attributable to elevated inflammatory tone, researchers “investigated the role of CB2 receptor on glucose tolerance and insulin sensitivity in high-fat diet (HFD)/streptozotocin (STZ)-induced mice.”

Read moreStudy: Cannabis a Potential Treatment Option for Insulin Resistance and Obesity-Related Diabetes